ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

CD28-Targeted Enzyme-Responsive Conformation-Switching Peptide Self-Assembly for Selective T-Cell Acute Lymphoblastic Leukemia (T-ALL) Therapy.

Jun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.